Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-10

Clinical Trial Update: Efficacy of Bifidobacterium Lactis CCT 7858 in Adults Using Antibiotics [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy of Bifidobacterium lactis CCT 7858 in adults using antibiotics for surgery-related infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bifidobacterium lactis CCT 7858 (Bifidobacterium lactis CCT 7858)

Snippet

Sponsor: Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude | Conditions: Surgery, Infection | Phase 2 | Status: COMPLETED